The role of Jak3 in lymphoid development, activation, and signaling

Current Opinion in Immunology

Volumn 9, Issue 4, 1997, Pages 541-547

  Thomis, Daniel C ^a   Berg, Leslie J ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; PROTEIN TYROSINE KINASE;

DEVELOPMENT; GENE MUTATION; HOMEOSTASIS; HUMAN; IMMUNE DEFICIENCY; LYMPHOID TISSUE; MOUSE; NONHUMAN; REVIEW;

EID: 0030867020     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80108-2     Document Type: Article

References (75)

1. Ihle JN. Cytokine receptor signaling. Nature. 377:1995;591-594.
2. Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Ohbo K, Nakamura M, Takeshita T. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol. 14:1996;179-205.
3. c. Immunol Rev. 138:1994;61-86.
4. c knockout (KO) mice, and presents some new data from an additional line of Jak3 KO mice.
5. Park SY, Saijo K, Takahashi T, Osawa M, Arase H, Hirayama N, Miyake K, Nakauchi H, Shirasawa T, Saito T. Developmental defects of lymphoid cells in JAK3 kinase-deficient mice. Immunity. 3:1995;771-782.
6. Nosaka T, van Deursen JMA, Tripp RA, Thierfelder WE, Witthuhn BA, McMickle AP, Doherty PC, Grosveld GC, Ihle JN. Defective lymphoid development in mice lacking JAK3. Science. 270:1995;800-802.
7. Thomis DC, Gurniak CB, Tivol E, Sharpe AH, Berg LJ. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking JAK3. Science. 270:1995;794-797.
8. DiSanto JP, Müller W, Guy-Grand D, Fischer A, Rajewsky K. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA. 92:1995;377-381.
9. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsall BL, Russell SM, Drago J, Noguchi M, Grinberg A, Bloom ET, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity. 2:1995;223-238.
10. Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ, et al. Mutations of JAK3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature. 377:1995;65-68.
11. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Javad Aman M, Migone T-S, Noguchi M, Markert ML, Buckley RH, et al. Mutation of JAK3 in a patient with SCID: essential role of JAK3 in lymphoid development. Science. 270:1995;797-800.
12. Leonard WJ. Dysfunctional cytokine receptor signaling in severe combined immunodeficiency. J Investig Med. 44:1996;304-311.
13. Notarangelo LD. Immunodeficiencies caused by genetic defects in protein kinases. Curr Opin Immunol. 8:1996;448-453.
14. Brooks EG, Schmalstieg FC, Wirt DP, Rosenblatt HM, Adkins LT, Lookingbill DP, Rudloff HE, Rakusan TA, Goldman AS. A novel X-linked combined immunodeficiency disease. J Clin Invest. 86:1990;1623-1631.
15. c chains with Jak1 and Jak3: implications for XSCID and XCID. Science. 266:1994;1042-1045.
16. Candotti F, Oakes SA, Johnston JA, Notarangelo LD, O'Shea JJ, Blaese RM. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction. of special interest J Exp Med. 183:1996;2687-2692 See annotation [19].
17. Candotti F, Johnston JA, Puck JM, Sugamura K, O'Shea JJ, Blaese RM. Retroviral-mediated gene correction for X-linked severe combined immunodeficiency. of special interest Blood. 87:1996;3097-3102 See annotation [19].
18. c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function. of special interest Blood. 87:1996;3108-3116 See annotation [19].
19. c-deficient patients.
20. Gurniak CB, Thomis DC, Berg LJ. Genomic structure and promoter region of the murine Janus-family tyrosine kinase, Jak3. of special interest DNA Cell Biol. 16:1997;85-94 See annotation [23].
21. Kumar A, Toscani A, Rane S, Reddy EP. Structural organization and chromosomal mapping of the Jak3 locus. of special interest Oncogene. 13:1996;2009-2014 See annotation [23].
22. Kono DH, Owens DG, Wechsler AR. Jak3 maps to chromosome 8. Mamm Genome. 7:1996;476-477.
23. Riedy MC, Dutra AS, Blake TB, Modi W, Lal BK, Davis J, Bosse A, O'Shea JJ, Johnston JA. Genomic sequence, organization, and chromosomal localization of human Jak3. of special interest Genomics. 37:1996;57-61 This paper, together with [20,21], describes the genomic structure and chromosomal localization of murine and human Jak3. These reports provide insight into the genetic lesions that give rise to the SCID phenotype.
24. Lai KS, Jin Y, Graham DK, Witthuhn BA, Ihle JN, Liu ET. A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells. J Biol Chem. 270:1995;25028-25036.
25. Gurniak CB, Berg LJ. Murine JAK3 is preferentially expressed in hematopoietic tissues and lymphocyte precursor cells. Blood. 87:1996;3151-3160.
26. Verbsky JW, Bach EA, Fang Y-F, Yang L, Randolph DA, Fields LE. Expression of Janus kinase 3 in human endothelial and other non-lymphoid and non-myeloid cells. J Biol Chem. 271:1996;13976-13980.
27. Cance WG, Liu ET. Protein kinases in human breast cancer. Breast Cancer Res Treat. 35:1995;105-114.
28. Xu X, Kang SH, Heidenreich O, Okerholm M, O'Shea JJ, Nerenberg MI. Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells. J Clin Invest. 96:1995;1548-1555.
29. Migone TS, Lin JX, Cereseto A, Mulloy JC, O'Shea JJ, Franchini G, Leonard WJ. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science. 269:1995;79-81.
30. Danial NN, Pernis A, Rothman PB. Jak-STAT signaling induced by the v-abl oncogene. Science. 269:1995;1875-1877.
31. Corcoran AE, Smart FM, Cowling RJ, Crompton R, Owen MJ, Venkitaraman R. The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. of special interest EMBO J. 15:1996;1924-1932 This paper describes two functions of the IL-7R in B lymphopoiesis: a role in proliferation and a role in promoting immunoglobulin heavy chain rearrangement leading to B cell differentiation. Interestingly, these two functions reside in separate regions of the IL-7Rα chain.
32. Tsuda S, Rieke S, Hashimoto Y, Nakauchi H, Takahama Y. IL-7 supports D-J but not V-DJ rearrangement of TCR-β gene in fetal liver progenitor cells. J Immunol. 156:1996;3233-3242.
33. Maki K, Sunaga S, Ikuta K. The V-J recombination of T cell receptor-gamma genes is blocked in interleukin-7 receptor-deficient mice. of outstanding interest J Exp Med. 184:1996;2423-2427 This report analyses TCR α, β, γ and δ gene rearrangements, as well as the expression of the recombination enzymes (recombination activation genes [RAGs] 1 and 2, Ku80 and terminal deoxynucleotidyl transferase), in the line of IL-7Rα KO mice with the milder defect in T cell development. The results indicate a specific absence of TCR γ V-J recombination, with all other TCR gene rearrangements and the expression of recombination enzymes being detectable at normal levels in thymocytes from this line.
34. Muegge K, Vila MP, Durum SK. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor β gene. Science. 261:1993;93-95.
35. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med. 181:1995;1519-1526.
36. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med. 180:1994;1955-1960.
37. Maki K, Sunaga S, Komagata Y, Kodaira Y, Mabuchi A, Karasuyama H, Yokomuro K, Miyazaki JI, Ikuta K. Interleukin 7 receptor-deficient mice lack gamma-delta T cells. of special interest Proc Natl Acad Sci USA. 93:1996;7172-7177 See annotation [39].
38. He YW, Malek TR. Interleukin-7 receptor alpha chain is essential for the development of gamma-delta+ T cells but not natural killer cells. of special interest J Exp Med. 184:1996;289-293 See annotation [39].
39. Moore TA, von Freeden-Jeffry U, Murray R, Zlotnik A. Inhibition of gamma-delta T cell development and early thymocyte maturation in IL-7-/- mice. of special interest J Immunol. 157:1996;2366-2373 Mice lacking IL-7 or the IL-7Rα chain, described in this report and [37,38], are found to lack γδ T cells in the spleen, intra-epithelial intestine, and the fetal thymus. In contrast, natural killer cells develop normally in these mice.
40. He YW, Nakajima H, Leonard WJ, Adkins B, Malek TR. The common γ-chain of cytokine receptors regulates intrathymic T cell development at multiple stages. J Immunol. 158:1997;2592-2599.
41. Maraskovsky E, Teepe M, Morrissey PJ, Braddy S, Miller RE, Lynch DH, Peschon JJ. Impaired survival and proliferation in IL-7-receptor-deficient peripheral T cells. of outstanding interest J Immunol. 157:1996;5315-5323 This report demonstrates that T cells from IL-7Rα deficient mice have reduced proliferative responses to antigenic and mitogenic stimulation, and that they undergo programmed cell death in culture by a Fas - FasL independent mechanism. This paper discusses the role of IL-7Rα in the receptor for TSLP.
42. Ray RJ, Furlonger C, Williams DE, Paige CJ. Characterization of thymic stromal-derived lymphopoietin (TSLP) in murine B cell development in vitro. of special interest Eur J Immunol. 26:1996;10-16 This report describes the novel growth factor TSLP, and shows evidence that TSLP has similar activites to IL-7, TSLP will replace IL-7 in promoting the proliferation and differentiation of B cell progenitors in vitro.
43. Leclercq G, Debacker V, de Smedt M, Plum J. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. of outstanding interest J Exp Med. 184:1996;325-336 See annotation [44].
44. c transduced severe combined immunodeficiency X1 bone marrow cells. of outstanding interest Blood. 88:1996;3901-3909 Along with [43], this report shows that IL-15, but not IL-2 or IL-7, can induce efficient natural killer (NK) cell differentiation from cord blood or bone marrow derived hematopoietic progenitor cells, as well as from thymic T/NK bipotential progenitor cells.
45. Suzuki H, Duncan GS, Takimoto H, Mak T. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. of special interest J Exp Med. 185:1997;499-505 This report describes the absence of NK cells and a reduction in intestinal intraepithelieal lymphocytes (IELs) in IL-2Rβ KO mice. Both TCRαβ CD8αα and TCRγδ IELs are reduced in these mice. These data indicate a role for IL-2 or IL-15 in the development of multiple subsets of extrathymic lymphocytes.
46. DiSanto JP, Guy-Grand D, Fisher A, Tarakhovsky A. Critical role for the common cytokine receptor γ chain in intrathymic and peripheral T cell selection. J Exp Med. 183:1996;1111-1118.
47. - thymocytes in these IL-7Rα KO mice have a reduced expression of the RAGs, and further, that the block in development can be overcome by the expression of a transgenic TCR. These data suggest that the IL-7Rα chain controls RAG expression and the initiation of TCR β chain VDJ rearrangement.
48. Saijo K, Park SY, Ishida Y, Arase H, Saito T. Crucial role of Jak3 in negative selection of self-reactive T cells. of special interest J Exp Med. 185:1997;351-356 This paper shows that the activated phenotype of peripheral T cells in Jak3 KO mice is dependent on antigenic signals through the TCR, and reports the failure of Jak3 KO mice to efficiently delete self-reactive thymocytes and T cells.
49. c KO mice is dependent on antigen receptor signaling. γc-deficient peripheral T cells are also shown to have increased rates of in vivo proliferation and cell death.
50. Thomis DC, Berg LJ. Peripheral expression of JAK3 is required to maintain T lymphocyte function. of outstanding interest J Exp Med. 185:1997;197-206 In this report, Jak3 expression is reconstituted in thymocytes, but not peripheral T cells, of Jak3 KO mice. The data show that the activated phenotype and functional nonresponsiveness of Jak3-deficient peripheral T cells does not result from aberrant T cell development in the thymus. This study also shows that expression of a kinase-inactive Jak3 gene cannot restore any of the defects seen in Jak3 KO mice.
51. Mueller DL, Seiffert S, Fang W, Behrens TW. Differential regulation of bcl-2 and bcl-x by CD3, CD28, and the IL-2 receptor in cloned CD4+ helper T cells. A model for the long-term survival of memory cells. J Immunol. 156:1996;1764-1771.
52. c chain of the IL-2 receptor. Science. 266:1994;1039-1042.
53. Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M, Krajewski S, Reed JC, Salmon M. Interleukin-2 receptor common gamma-chain signaling cyokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol. 26:1996;294-299.
54. Armant M, Delespesse G, Sarfati M. IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression. Immunology. 85:1995;331-337.
55. Sadlack B, Lohler J, Schorle H, Klebb G, Haber H, Sickel E, Noelle RJ, Horak I. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an incontrolled activation and proliferation of CD4+ T cells. Eur J Immunol. 25:1995;3053-3059.
56. Kneitz B, Herrmann T, Yonehara S, Schimpl A. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur J Immunol. 25:1995;2572-2577.
57. Willerford DM, Chen JZ, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity. 3:1995;521-530.
58. Suzuki H, Kundig TM, Furlonger C, Wakeham A, Timms E, Matsuyama T, Schmits R, Sirnard JJL, Ohashi PS, Griesser H, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science. 268:1995;1472-1476.
59. Johnston JA, Bacon CM, Riedy MC, O'Shea JJ. Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency. J Leukoc Biol. 60:1996;441-452.
60. Schindler C, Darnell JEJ. Transcriptional responses to polypeptide ligands: the Jak-STAT pathway. Annu Rev Biochem. 64:1995;621-651.
61. Lai SY, Xu W, Gaffen SL, Liu KD, Longmore GD, Greene WC, Goldsmith MA. The molecular role of the common gamma c subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes. Proc Natl Acad Sci USA. 93:1996;231-235.
62. Miyazaki T, Taniguchi T. Coupling of the IL-2 receptor complex with non-receptor protein tyrosine kinases. Cancer Surv. 27:1996;25-40.
63. c, IL-4-induced phosphorylation of Jak1, STAT6, insulin receptor substrate (IRS)-1, and IRS-2 were detectable.
64. c (PROX) in tandem with Jak3 functioned to induce T cell proliferation. In contrast, PROX alone in the absence of tandem Jak3, was sufficient to induce cytokine-mediated IL-2Rβ and SH2 domain containing phosphotyrosine phosphatase (SHP)-2 phosphorylation.
65. Taniguchi T, Miyazaki T, Minami Y, Kawahara A, Fujii H, Nakagawa Y, Hatakeyama M, Liu ZJ. IL-2 signaling involves recruitment and activation of multiple protein tyrosine kinases by the IL-2 receptor. Ann N Y Acad Sci. 766:1995;235-244.
66. Izuhara K, Feldman RA, Greer P, Harada N. Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase. Blood. 88:1996;3910-3918.
67. Page TH, Lali FV, Foxwell BM. Interleukin-7 activates p561ck and p59fyn, two tyrosine kinases associated with the p90 interleukin-7 receptor in primary human T cells. Eur J Immunol. 25:1995;2956-2960.
68. Ikizawa K, Kajiwara K, Basaki Y, Koshio T, Yanagihara Y. Evidence for a role of phosphatidylinositol 3-kinase in IL-4-induced germline C epsilon transcription. Cell Immunol. 170:1996;134-140.
69. Sharfe N, Dadi HK, Roifman CM. JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3′ kinase. Blood. 86:1995;2077-2085.
70. Kawahara A, Minami Y, Miyazaki T, Ihle JN, Taniguchi T. Critical role of the interleukin 2 (IL-2) receptor γ-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc Natl Acad Sci USA. 92:1995;8724-8728.
71. Yin T, Keller SR, Quelle FW, Witthuhn BA, Tsang ML, Lienhard GE, Ihle JN, Yang YC. Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via Jak tyrosine kinases. J Biol Chem. 270:1995;20497-20502.
72. Johnston JA, Wang L-M, Hanson EP, Sun X-J, White MF, Oakes SA, Pierce JH, O'Shea JJ. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. J Biol Chem. 270:1995;28527-28530.
73. Yin T, Shen R, Feng GS, Yang YC. Molecular characterization of specific interactions between SHP-2 phosphatase and Jak tyrosine kinases. J Biol Chem. 272:1997;1032-1037.
74. Fusaki N, Iwamatsu A, Iwashima M, Fujisawa J-I. Interaction between Sam68 and src family tyrosine kinases, fyn and lck, in T cell receptor signaling. of special interest J Biol Chem. 272:1997;6214-6219 This report describes the association of the T cell receptor signaling molecule Sam68 with Jak3.
75. Streuli M. Protein tyrosine phosphatases in signaling. Curr Opin Cell Biol. 8:1996;182-188.